The invention relates to a novel compound termed NKp30 that is selectively expressed by all mature NK cells and that is involved in human natural cytoxicity as an activatory receptor, to new antibodies that bind to the NKp30 structure, and to the pharmaceutical and medicinal uses thereof.

 
Web www.patentalert.com

< Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof

< Method for preparing a biological fertilizer composition comprising poultry manure

> Method of modifying the content of cottonseed oil

> Human ion channel proteins
~ 00230